|
1
|
Mathkour M, Garces J, Beard B, Bartholomew
A, Sulaiman OA and Ware ML: Primary high-grade osteosarcoma of the
clivus: A case report and literature review. World Neurosurg.
89:730.e9–730.e13. 2016. View Article : Google Scholar
|
|
2
|
Zheng YF, Lin J and Yang HL:
Chondroblastic osteosarcoma secondary to fibrosarcoma: A case
report and literature review. Oncol Lett. 10:3573–3576. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Friebele JC, Peck J, Pan X, Abdel-Rasoul M
and Mayerson JL: Osteosarcoma: A meta-analysis and review of the
literature. Am J Orthop (Belle Mead NJ). 44:547–553.
2015.PubMed/NCBI
|
|
4
|
Tsagaraki I, Tsilibary EC and Tzinia AK:
TIMP-1 interaction with alphavbeta3 integrin confers resistance to
human osteosarcoma cell line MG-63 against TNF-α-induced apoptosis.
Cell Tissue Res. 342:87–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Locklin RM, Federici E, Espina B, Hulley
PA, Russell RG and Edwards CM: Selective targeting of death
receptor 5 circumvents resistance of MG-63 osteosarcoma cells to
TRAIL-induced apoptosis. Mol Cancer Ther. 6:3219–3228. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dell'Amore A, Asadi N, Caroli G, Dolci G,
Bini A and Stella F: Recurrent primary cardiac osteosarcoma: A case
report and literature review. General Thorac Cardiovasc Surg.
62:175–180. 2014. View Article : Google Scholar
|
|
7
|
Farcas N, Arzi B and Verstraete FJ: Oral
and maxillofacial osteosarcoma in dogs: A review. Vet Comp Oncol.
12:169–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shangguan L, Ti X, Krause U, Hai B, Zhao
Y, Yang Z and Liu F: Inhibition of TGF-β/Smad signaling by BAMBI
blocks differentiation of human mesenchymal stem cells to
carcinoma-associated fibroblasts and abolishes their protumor
effects. Stem Cells. 30:2810–2819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guillot N, Kollins D, Gilbert V, Xavier S,
Chen J, Gentle M, Reddy A, Bottinger E, Jiang R, Rastaldi MP, et
al: BAMBI regulates angiogenesis and endothelial homeostasis
through modulation of alternative TGFβ signaling. PloS one.
7:e394062012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fritzmann J, Morkel M, Besser D, Budczies
J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM and
Birchmeier W: A colorectal cancer expression profile that includes
transforming growth factor beta inhibitor BAMBI predicts metastatic
potential. Gastroenterology. 137:165–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khin SS, Kitazawa R, Win N, Aye TT, Mori
K, Kondo T and Kitazawa S: BAMBI gene is epigenetically silenced in
subset of high-grade bladder cancer. Int J Cancer. 125:328–338.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miao S, Zhao L, Gao J, Wang H and Cui Z:
Distribution and mRNA expression of BAMBI in non-small-cell lung
cancer. Zhongguo Fei Ai Za Zhi. 12:203–207. 2009.(In Chinese).
PubMed/NCBI
|
|
13
|
Pils D, Wittinger M, Petz M, Gugerell A,
Gregor W, Alfanz A, Horvat R, Braicu EI, Sehouli J, Zeillinger R,
et al: BAMBI is overexpressed in ovarian cancer and co-translocates
with Smads into the nucleus upon TGF-beta treatment. Gynecol Oncol.
117:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu K, Song X, Ma H, Liu L, Wen X, Yu J,
Wang L and Hu S: Knockdown of BAMBI inhibits β-catenin and
transforming growth factor β to suppress metastasis of gastric
cancer cells. Mol Med Rep. 10:874–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marwitz S, Depner S, Dvornikov D, Merkle
R, Szczygieł M, Müller-Decker K, Lucarelli P, Wäsch M, Mairbäurl H,
Rabe KF, et al: Downregulation of the TGFβ Pseudoreceptor BAMBI in
non-small cell lung cancer enhances tgfbeta signaling and invasion.
Cancer Res. 76:3785–3801. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xing W, Zhigang W, Bing H, Haitao R, Pan
L, Chuanshan X, Yuanyi Z and Ao L: Targeting an ultrasound contrast
agent to folate receptors on ovarian cancer cells: Feasibility
research for ultrasonic molecular imaging of tumor cells. J
Ultrasound Med. 29:609–614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi X, DiRenzo D, Guo LW, Franco SR, Wang
B, Seedial S and Kent KC: TGF-beta/Smad3 stimulates stem
cell/developmental gene expression and vascular smooth muscle cell
de-differentiation. PloS One. 9:e939952014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Renshaw A and Elsheikh TM: A validation
study of the Focalpoint GS imaging system for gynecologic cytology
screening. Cancer Cytopathol. 121:737–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bai FL, Yu YH, Tian H, Ren GP, Wang H,
Zhou B, Han XH, Yu QZ and Li DS: Genetically engineered Newcastle
disease virus expressing interleukin-2 and TNF-related
apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther.
15:1226–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuang T, Djemil T, Qi P, Magnelli A,
Stephans K, Videtic G and Xia P: Dose calculation differences
between Monte Carlo and pencil beam depend on the tumor locations
and volumes for lung stereotactic body radiation therapy. J Appl
Clin Med Phys. 14:40112013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Durfee RA, Mohammed M and Luu HH: Review
of osteosarcoma and current management. Rheumatol Ther. 3:221–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He F, Zhang W, Shen Y, Yu P, Bao Q, Wen J,
Hu C and Qiu S: Effects of resection margins on local recurrence of
osteosarcoma in extremity and pelvis: Systematic review and
meta-analysis. Int J Surg. 36:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heaton TE, Hammond WJ, Farber BA, Pallos
V, Meyers PA, Chou AJ, Price AP and LaQuaglia MP: A 20-year
retrospective analysis of CT-based pre-operative identification of
pulmonary metastases in patients with osteosarcoma: A single-center
review. J Pediatr Surg. 52:115–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Angelini A, Mavrogenis AF, Trovarelli G,
Ferrari S, Picci P and Ruggieri P: Telangiectatic osteosarcoma: A
review of 87 cases. J Cancer Res Clin Oncol. 142:2197–2207. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bilbao-Aldaiturriaga N, Askaiturrieta Z,
Granado-Tajada I, Goričar K, Dolžan V; For The Slovenian
Osteosarcoma Study Group, ; Garcia-Miguel P, Garcia de Andoin N,
Martin-Guerrero I and Garcia-Orad A: A systematic review and
meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility.
Pediatr Res. 80:472–479. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu K, Dai HB and Qiu ZL: mTOR signaling in
osteosarcoma: Oncogenesis and therapeutic aspects (Review). Oncol
Rep. 36:1219–1225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sekiya T, Adachi S, Kohu K, Yamada T,
Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S,
et al: Identification of BMP and activin membrane-bound inhibitor
(BAMBI), an inhibitor of transforming growth factor-beta signaling,
as a target of the beta-catenin pathway in colorectal tumor cells.
J Biol Chem. 279:6840–6846. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pak KH, Kim DH, Kim H, Lee do H and Cheong
JH: Differences in TGF-β1 signaling and clinicopathologic
characteristics of histologic subtypes of gastric cancer. BMC
Cancer. 16:602016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim
CY and Yoon JH: Hypoxia enhances tumor-stroma crosstalk that drives
the progression of hepatocellular carcinoma. Dig Dis Sci.
61:2568–2577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou L, Park J, Jang KY, Park HS, Wagle S,
Yang KH, Lee KB, Park BH and Kim JR: The overexpression of BAMBI
and its involvement in the growth and invasion of human
osteosarcoma cells. Oncol Rep. 30:1315–1322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tu B, Peng ZX, Fan QM, Du L, Yan W and
Tang TT: Osteosarcoma cells promote the production of pro-tumor
cytokines in mesenchymal stem cells by inhibiting their osteogenic
differentiation through the TGF-β/Smad2/3 pathway. Exp Cell Res.
320:164–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schedlich LJ, Yenson VM and Baxter RC:
TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in
human osteosarcoma cells. Mol Cell Endocrinol. 377:56–64. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu L, Liu S, Guo W, Zhang C, Zhang B, Yan
H and Wu Z: hTERT promoter activity identifies osteosarcoma cells
with increased EMT characteristics. Oncol Lett. 7:239–244. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang G, Yuan J and Li K: EMT transcription
factors: Implication in osteosarcoma. Med Oncol. 30:6972013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsubaki M, Yamazoe Y, Yanae M, Satou T,
Itoh T, Kaneko J, Kidera Y, Moriyama K and Nishida S: Blockade of
the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the
expression of bFGF, HGF and TGF-β as angiogenic factors in mouse
osteosarcoma. Cytokine. 54:100–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang D, Jiang F, Wang X and Li G:
Downregulation of ubiquitin-specific protease 22 inhibits
proliferation, invasion and EMT in osteosarcoma cells. Oncol Res.
25:743–751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wendt MK, Tian M and Schiemann WP:
Deconstructing the mechanisms and consequences of TGF-β-induced EMT
during cancer progression. Cell Tissue Res. 347:85–101. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kitazawa S, Kitazawa R, Obayashi C and
Yamamoto T: Desmoid tumor with ossification in chest wall: Possible
involvement of BAMBI promoter hypermethylation in metaplastic bone
formation. J Bone Miner Res. 20:1472–1477. 2005. View Article : Google Scholar : PubMed/NCBI
|
